001     875339
005     20210130004919.0
024 7 _ |a 10.1093/ejcts/ezz240
|2 doi
024 7 _ |a 1010-7940
|2 ISSN
024 7 _ |a 1567-4258
|2 ISSN
024 7 _ |a 1873-734X
|2 ISSN
024 7 _ |a 1878-3309
|2 ISSN
024 7 _ |a 2128/26185
|2 Handle
024 7 _ |a pmid:31501891
|2 pmid
024 7 _ |a WOS:000501730300014
|2 WOS
037 _ _ |a FZJ-2020-01962
082 _ _ |a 610
100 1 _ |a Minol, Jan-Philipp
|0 P:(DE-HGF)0
|b 0
245 _ _ |a The age-adjusted Charlson comorbidity index in minimally invasive mitral valve surgery
260 _ _ |a Oxford
|c 2019
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1605606575_21575
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a OBJECTIVESMitral valve repair is the preferred method used to address mitral valve regurgitation, whereas transcatheter mitral valve repair is recommended for high-risk patients. We evaluated the risk-predictive value of the age-adjusted Charlson comorbidity index (aa-CCI) in the setting of minimally invasive mitral valve surgery.METHODSThe perioperative course and 1-year follow-up of 537 patients who underwent isolated or combined minimally invasive mitral valve surgery were evaluated for 1-year mortality as the primary end point and other adverse events. The predictive values of the EuroSCORE II and STS score were compared to that of the aa-CCI by a comparative analysis of receiver operating characteristic curves. Restricted cubic splines were applied to find optimal aa-CCI cut-off values for the increased likelihood of experiencing the predefined adverse end points. Consequently, the perioperative course and postoperative outcome of the aa-CCI ≥8 patients and the remainder of the sample were analysed.RESULTSThe predictive value of the aa-CCI does not significantly differ from those of the EuroSCORE II or STS score. Patients with an aa-CCI ≥8 were identified as a subgroup with a significant increase of mortality and other adverse events.CONCLUSIONSThe aa-CCI displays a suitable predictive ability for patients undergoing minimally invasive mitral valve surgery. In particular, multimorbid or frail patients may benefit from the extension of the objectively assessed parameters, in addition to the STS score or EuroSCORE II. Patients with an aa-CCI ≥8 have a very high surgical risk and should receive very careful attention.
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Dimitrova, Vanessa
|0 0000-0003-0152-8803
|b 1
700 1 _ |a Petrov, Georgi
|0 0000-0002-1045-6592
|b 2
700 1 _ |a Langner, Robert
|0 P:(DE-Juel1)131693
|b 3
700 1 _ |a Boeken, Udo
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Rellecke, Philipp
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Aubin, Hug
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Kamiya, Hiroyuki
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Sixt, Stephan
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Huhn, Ragnar
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Sugimura, Yukiharu
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Albert, Alexander
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Lichtenberg, Artur
|0 P:(DE-HGF)0
|b 12
|e Corresponding author
700 1 _ |a Akhyari, Payam
|0 0000-0002-6452-8678
|b 13
773 _ _ |a 10.1093/ejcts/ezz240
|g Vol. 56, no. 6, p. 1124 - 1130
|0 PERI:(DE-600)1500330-9
|n 6
|p 1124 - 1130
|t European journal of cardio-thoracic surgery
|v 56
|y 2019
|x 1873-734X
856 4 _ |u https://juser.fz-juelich.de/record/875339/files/ezz240.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:875339
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)131693
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J CARDIO-THORAC : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21